ION Acquisition Corp 2 raises $220m for IPO

ION Acquisition Corp 2, a second blank check company formed by ION Asset Management targeting an Israeli tech business, has raised $220 million for its IPO after pricing its 22 million shares at $10 per share.

ION Acquisition Corp 2, a second blank check company formed by ION Asset Management targeting an Israeli tech business, has raised $220 million for its IPO after pricing its 22 million shares at $10 per share. The stock began trading February 11, 2021 on the New York Stock Exchange under the ticker symbol “IACB.U.” Goldman Sachs and Morgan Stanley are the lead underwriters.

PRESS RELEASE

NEW YORK–(BUSINESS WIRE)–ION Acquisition Corp 2 Ltd. (the “Company”) announced today the pricing of its initial public offering of 22,000,000 units at a price of $10.00 per unit. The units will be listed on The New York Stock Exchange (the “NYSE”) and trade under the ticker symbol “IACB.U” beginning on February 11, 2021. Each unit consists of one Class A ordinary share and one-eighth of one redeemable warrant, with each whole warrant exercisable to purchase one Class A ordinary share at a price of $11.50 per share. After the securities comprising the units begin separate trading, the Class A ordinary shares and warrants are expected to be listed on the NYSE under the symbols “IACB” and “IACB WS,” respectively. The offering is expected to close on February 16, 2021.

The Company is a blank check company incorporated for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. While the Company may pursue a business combination target in any business or industry, the Company intends to focus on the rapidly growing universe of Israeli companies and entrepreneurs that apply technology and innovation to our everyday lives. The Company is sponsored by ION Holdings 2, LP, an affiliate of ION Asset Management Ltd.

Goldman Sachs & Co. LLC and Morgan Stanley are serving as joint book-running managers for the offering. AmeriVet Securities is acting as co-manager for the offering. The Company has granted the underwriters a 45-day option to purchase up to an additional 3,300,000 units at the initial public offering price to cover over-allotments, if any.

The offering is being made only by means of a prospectus. When available, copies of the prospectus relating to this offering may be obtained from: Goldman Sachs & Co. LLC, Attn: Prospectus Department, 200 West Street, New York, New York 10282, by telephone: 866-471-2526 or email: prospectus-ny@ny.email.gs.com or Morgan Stanley & Co. LLC, Attn: Prospectus Department, 180 Varick Street, Second Floor, New York, New York 10014.

A registration statements relating to these securities became effective on February 10, 2021. This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.